Abstract
Rhabdomyosarcoma, the most common soft tissue sarcoma of children, carried a 10–15% survival rate in the late 1960s. Since then, better understanding of biology and pathology of the tumor and the judicious use of chemotherapy and radiation has improved the prognosis drastically. In addition instead of extirpative surgery, organ salvage is now feasible in many of these children. In this article the authors review current information regarding pathology, diagnosis and treatment of rhabdomyosarcoma
Similar content being viewed by others
References
LaQuaglia MP. Rhabdomyosarcoma and Nonrhabdomyomatous Sarcomas. In Oldham KT, Colombani PM, FogliaRP, eds.Surgery of Infants and Children: Scientific Principles and Practice, Philadelphia, PA, Lippincott-Raven, 1997; 615–631.
Raney RB, Anderson JR, Barr FGet al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study group experience and rationale for Intergroup Rhabdomyosarcoma Study V,J Pediatr Hematol/Oncol 2001; 23: 215–220.
Crist W, Gehan EA, Ragab AHet al. The Third Intergroup Rhabdomyosarcoma Study.J Clin Oncol 1995; 13: 610–630.
Crist WM, Anderson JR, Meza JLet al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease.J Clin Oncol 2001; 19: 3091–3102.
Maurer HM, Beltangady M, Gehan EAet al. The Intergroup Rhabdomyosarcoma Study-I: A final report.Cancer 1988; 61: 209–20.
Maurer HM, Gehan EA, Beltangady Met al The Intergroup Rhabdomyosarcoma Study-II.Cancer 1993; 71:1904–22.
Rhabdomyosarcoma. In O’Neill JA Jr, Grosfeld JL, FonkalsrudEW, Coran AG, Caldamone AA, eds.Principles of Pediatric Surgery. 2nd edn. St. Louis, MO 2003, Mosby, Pp. 229–238.
Wiener ES. Rhabdomyosarcoma. In O’Neill JA Jr, Rowe MI, Grosfeld JL, Fonkalsrud EW, Coran AG, eds.Pediatric Surgery, 5th edn. St. Louis, MO, 1998, Mosby, pp 431–445.
Newton WA Jr, Hamoudi A, Webber Bet ai Pathology of rhabdomyosarcoma and related tumors. In Maurer HM, Ruymann FB, Pochedly C, eds.Rhabdomyosarcoma and Related Tumors in Children and Adolescents, Boca Raton, FL, CRC, 1991, 19–48.
Pappo AS, Crist WM, Kuttesch Jet al. Tumor-cell DNA content predicts outcome in children and adolescents with Clinical Group III embryonal rhabdomyosarcoma.J Clin Oncol 1993; 11:1901–1905.
Shapiro DN, Parham DM, Douglass ECet al. Relationship of tumor-cell ploidy to histologie subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.J Clin Oncol 1991; 9: 159–166.
Ruymann FB. Rhabdomyosarcoma in children and adolescents: a review.Hematol Oncol Clin North Am 1987; 1: 621–654.
Raney RB Jr. Rhabdomyosarcoma and related tumors of the head and neck in childhood. In Maurer HM, Ruymann FB, Pochedly C, eds.Rhabdomyosarcoma and Related Tumors in Children and Adolescents, Boca Raton, FL, 1991, CRC, 319–332.
Gehan Eet al. Considerations in the development of a staging system for rhabdomyosarcoma, SIOP XIX Meeting, Jerusalem, 1987.
Newton WA, Gehan EA, Webber BLet al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification. An intergroup rhabdomosarcoma study.Cancer 1995; 76:1073–1085.
Donaldson SS. Rhabdomyosarcoma: contemporary status and future directions.Arch Surgery 1989; 124:1015–1020.
Crist W, Anderson J, Maurer Het al. Preliminary results for patients with local/regional tumors treated on the Intergroup Rhabdomyosarcoma Study-IV (1991–1997) (abstract 2141).Proc Am Soc Clin Oncol 1999; 18: 555a.
Hays DM. New approaches to the surgical management of rhabdomyosarcoma in childhood.Chir Pediatr 1990; 31:197–201.
Lawrence W. Surgical principles in the management of sarcomas in children. In Maurer HM, Ruymann FB, PochedlyC, eds.Rhabdomyosarcoma and Related Tumors in Children and Adolescents, Boca Raton, FL, 1991, CRC, Pp. 171–180.
Wiener ES. Rhabdomyosarcoma: New Dimensions in management.Semin Pediatr Surg 1993; 2:47–58.
Hays DM, Lawrence W Jr, Wharam Met al. Primary reexcision for patients with “microscopic residual” following initial excision of sarcomas of trunk and extremity sites.J Pediatr Surg 1989; 24: 5–10.
Mandell LR. Ongoing progress in the treatment of childhood rhabdomyosarcoma.Oncology 1993; 7: 71–83.
Hays DM, Raney RB, Crist WMet al. Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy responsive stage III-IV sarcomas. A report from the Intergroup Rhabdomyosarcoma Study.J Ped Surg 1990; 25: 1100–1105.
Wolden SL, Anderson JR, Crist WMet al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.J Clin Oncol 1999; 17:3468–3475.
Tefft M. Radiation therapy guidelines in rhabdomyosarcoma: results of the Intergroup Rhabdomyosarcoma Studies. In Maurer HM, Ruymann FB, Pochedly C, eds.Rhabdomyosarcoma and Related Tumors in Children and Adolescents. Boca Raton, FL, CRC 1991; 181–186.
Arndt C, Tefft M, Gehan Eet al. A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study.J Pediatr Hematol/Oncol 1997; 19:124–129.
Anderson JR, Ruby E, Link Met al. Identification of a favorable subset of patients (pts) with metastatic (MET) rhabdomosarcoma (RMS): A report from the Intergroup Rhabdomyosarcoma Study Group (IRSG) (abstract 1836).Proc Am Soc Clin Oncol 1997; 16: 510a.
Kurie JM. The biologic basis for the use of retinoids in cancer prevention and treatment.Cur Opin in Oncol 1999; 11:497–502.
LeRoith D, Baserga R, Helman Let al. Insulin-like growth factors and cancer.Ann. Int Med 1995; 122: 54–59.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stuart, A., Radhakrishnan, J. Rhabdomyosarcoma. Indian J Pediatr 71, 331–337 (2004). https://doi.org/10.1007/BF02724100
Issue Date:
DOI: https://doi.org/10.1007/BF02724100